To test whether DSP-4-mediated degeneration of dopaminergic neurons in the 6OHDA model of PD is dependent on DSP-4 interaction with NET, we use desipramine, a reversible NET blocker [25]. Here, SLC6A2 is linked to Parkinson disease.